pargyline has been researched along with plomestane in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (52.00) | 18.7374 |
1990's | 12 (48.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
di Salle, E; Giudici, D; Ornati, G; Panzeri, A; Zaccheo, T | 1 |
Johnston, JO; Leeson, GA; Wright, CL | 1 |
Gomez-Sanchez, CE; Gomez-Sanchez, EP | 1 |
Doody, KM; Mason, JI; Murry, BA | 1 |
Griffing, GT; Holbrook, M; Johnston, ON; Melby, JC | 1 |
Brandt, ME; Brodie, AM; Melner, MH; Puett, D; Zimniski, SJ | 1 |
Benson, HD; Holbert, GW; Johnston, JO; Wright, CL | 1 |
Brandt, ME; Covey, DF; Zimniski, SJ | 1 |
Briatico, G; di Salle, E; Giudici, D; Ornati, G | 1 |
Briatico, G; di Salle, E; Giudici, D; Ornati, G; Zaccheo, T | 1 |
Alberta, J; Griffing, GT; Holbrook, M; Melby, JC; Orme-Johnson, NR | 1 |
Johnston, JO; Shumaker, RC; Wright, CL | 1 |
Brandt, ME; Covey, DF; Fendl, K; Garola, R; Puett, D; Zimniski, SJ | 1 |
Femino, A; Johnston, JO; Longcope, C | 1 |
Brandt, ME; Covey, DF; Puett, D; Zimniski, SJ | 2 |
Berkovitz, GD; Brown, TR; Kruter, RH; Migeon, CJ | 1 |
Griffing, GT; Holbrook, M; Johnston, JO; Melby, JC | 1 |
Brandt, ME; Covey, DF; Melner, MH; Puett, D; Zimniski, SJ | 1 |
Johnston, JO; Metcalf, BW; Wright, CL | 2 |
Covey, DF; Etre, LA; MacIndoe, JH; Woods, GR | 1 |
Covey, DF; Davis, SP; Killinger, DW; Perel, E | 1 |
Holbert, GW; Johnston, JO; Wright, CL | 1 |
Brodie, AM | 1 |
2 review(s) available for pargyline and plomestane
Article | Year |
---|---|
Aromatase and aromatase inhibitors: from enzymology to selective chemotherapy.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Neoplasms, Hormone-Dependent; Pargyline; Rats | 1988 |
Aromatase, its inhibitors and their use in breast cancer treatment.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Half-Life; Humans; Neoplasms, Hormone-Dependent; Pargyline | 1993 |
1 trial(s) available for pargyline and plomestane
Article | Year |
---|---|
Enzyme-activated inhibitors of steroidal hydroxylases.
Topics: Adrenal Cortex Hormones; Androstenedione; Animals; Aromatase Inhibitors; Cytochrome P-450 CYP11B2; Cytochrome P-450 Enzyme Inhibitors; Desoxycorticosterone; Drug Tolerance; Estrogens; Humans; Male; Mineralocorticoids; Pargyline; Rats; Rats, Sprague-Dawley; Receptors, Steroid; Steroid 11-beta-Hydroxylase; Steroid Hydroxylases; Zona Glomerulosa | 1995 |
22 other study(ies) available for pargyline and plomestane
Article | Year |
---|---|
Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cell Division; Dose-Response Relationship, Drug; Endocrine Glands; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Organ Size; Ovariectomy; Pargyline; Prolactin; Rats | 1991 |
Regioselectivity of metabolic activation of acetylenic steroids by hepatic cytochrome P450 isozymes.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Biotransformation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Isoenzymes; Liver; Male; Norethindrone; Pargyline; Pentobarbital; Rats; Rats, Inbred Strains; Sleep | 1991 |
The effect of gonadectomy and aromatase inhibition on the excretion of 19-nordeoxycorticosterone in rats.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Castration; Desoxycorticosterone; Estrogens; Female; Gonads; Male; Pargyline; Rats; Testosterone | 1991 |
The use of rat Leydig tumor (R2C) and human hepatoma (HEPG2) cells to evaluate potential inhibitors of rat and human steroid aromatase.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Carcinoma, Hepatocellular; Cell Line; Drug Screening Assays, Antitumor; Humans; Kinetics; Leydig Cell Tumor; Liver Neoplasms; Male; Pargyline; Rats; Testicular Neoplasms | 1990 |
Antihypertensive effects of an aromatase inhibitor in inbred salt-sensitive rats.
Topics: Aldosterone; Androstenedione; Animals; Antihypertensive Agents; Aromatase Inhibitors; Cortisone; Desoxycorticosterone; Female; Hypertension; Male; Pargyline; Rats; Rats, Inbred Strains; Sodium Chloride | 1991 |
Effect of 4-hydroxyandrostenedione on murine Leydig tumor cell steroidogenesis.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Leydig Cell Tumor; Male; Mice; Pargyline; Pregnenolone; Progesterone; Testosterone | 1991 |
Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962).
Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Biotransformation; Female; Humans; Indicators and Reagents; Kinetics; Microsomes; Pargyline; Placenta; Structure-Activity Relationship | 1990 |
The effects of in vivo administration of 10-propargylestr-4-ene-3,17-dione on rat ovarian aromatase and estrogen levels.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Estradiol; Estrogens; Estrus; Female; Injections, Subcutaneous; Kinetics; Ovary; Pargyline; Proestrus; Rats; Reference Values | 1990 |
Novel irreversible aromatase inhibitors.
Topics: Aminoglutethimide; Androstadienes; Androstenedione; Animals; Aromatase Inhibitors; Female; Gonadotropins, Equine; Humans; In Vitro Techniques; Kinetics; Microsomes; Ovary; Pargyline; Placenta; Rats; Rats, Inbred Strains | 1990 |
Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Female; Humans; Luteinizing Hormone; Male; Mammary Neoplasms, Experimental; Microsomes; Orchiectomy; Ovary; Pargyline; Placenta; Pregnancy; Rats; Rats, Inbred Strains; Reference Values | 1989 |
19-Hydroxylase inhibition of adrenal mitochondrial P450 11 beta/18/19-hydroxylase by a suicide inhibitor.
Topics: Adrenal Glands; Adrenodoxin; Androstenedione; Animals; Cattle; Cytochrome P-450 CYP11B2; Cytochrome P-450 Enzyme Inhibitors; Desoxycorticosterone; Ferredoxin-NADP Reductase; Hydroxylation; In Vitro Techniques; Mitochondria; Pargyline; Steroid 11-beta-Hydroxylase; Steroid Hydroxylases | 1989 |
Human trophoblast xenografts in athymic mice: a model for peripheral aromatization.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Choriocarcinoma; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Ovary; Pargyline; Pregnancy; Tissue Distribution; Tumor Cells, Cultured | 1989 |
Inhibition of peripheral aromatization in baboons by an enzyme-activated aromatase inhibitor (MDL 18,962).
Topics: Androstenedione; Animals; Aromatase Inhibitors; Carbon Radioisotopes; Estradiol; Estrone; Female; Kinetics; Metabolic Clearance Rate; Papio; Pargyline; Reference Values; Testosterone; Tritium | 1988 |
Characterization of pregnant mare's serum gonadotropin-stimulated rat ovarian aromatase and its inhibition by 10-propargylestr-4-ene-3,17-dione.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Female; Gonadotropins, Equine; Humans; Kinetics; Microsomes; Ovary; Pargyline; Placenta; Pregnancy; Rats; Reference Values | 1988 |
Effects of 10-(2-propynyl)-estr-4-ene-3,17-dione (MDL 18,962)--a mechanism-based irreversible inhibitor of aromatase--in cultured human foreskin fibroblasts.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Androstenedione; Aromatase Inhibitors; Cells, Cultured; Dihydrotestosterone; Fibroblasts; Humans; Infant, Newborn; Male; Pargyline; Penis; Receptors, Androgen; Skin | 1987 |
Antihypertensive effects of an aromatase inhibitor in the spontaneously hypertensive rat.
Topics: Aging; Androstenedione; Animals; Blood Pressure; Desoxycorticosterone; Hypertension; Male; Pargyline; Rats; Rats, Inbred SHR | 1987 |
Inhibition of Leydig tumor cell steroidogenesis by 10-propargylestr-4-ene-3,17-dione, an irreversible aromatase inhibitor.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Leydig Cell Tumor; Male; Mice; Mice, Inbred C57BL; Oxidoreductases; Pargyline; Pregnenolone; Progesterone; Testicular Neoplasms; Testosterone | 1985 |
Time-dependent inhibition of aromatase in trophoblastic tumor cells in tissue culture.
Topics: Androstenedione; Aromatase Inhibitors; Cell Line; Choriocarcinoma; Estrogens; Female; Humans; Kinetics; Oxidoreductases; Pargyline; Pregnancy; Uterine Neoplasms | 1984 |
Biochemical and endocrine properties of a mechanism-based inhibitor of aromatase.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Biomechanical Phenomena; Chemical Phenomena; Chemistry; Endocrine Glands; Enzyme Inhibitors; Female; Humans; Male; Mice; Mice, Inbred Strains; Ovary; Oxidoreductases; Pargyline; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1984 |
Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cell Line; Dihydrotestosterone; Estradiol; Female; Humans; Oxidoreductases; Pargyline; Receptors, Estrogen; Receptors, Progesterone; Testolactone; Testosterone | 1982 |
Effects of 4-hydroxy-4-androstene-3, 17-dione and 10-propargylestr-4-ene-3, 17-dione on the metabolism of androstenedione in human breast carcinoma and breast adipose tissues.
Topics: Adipose Tissue; Androstenedione; Breast; Breast Neoplasms; Female; Humans; Kinetics; Pargyline | 1981 |
Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cell Division; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogens; Estrus; Female; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Pargyline; Rats; Rats, Sprague-Dawley | 1993 |